Joab Chapman

Title: Joab Chapman: Innovator in Medical Research

Introduction

Joab Chapman is a notable inventor based in Kiryat Ono, Israel. He has made significant contributions to the field of medical research, particularly in the development of methods and treatments related to thrombus identification and inflammation.

Latest Patents

Chapman holds 5 patents that showcase his innovative work. His latest patents include "Methods and kits for identifying thrombus origin and optimizing post-ischemic event treatment," which provides methods and kits for identifying thrombus origin based on temporal thrombin activity assay. This invention aims to optimize post-ischemic event treatment and prevent the recurrence of secondary ischemic events. Another significant patent is "Peptides that inhibit binding of EPCR to its ligand to treat inflammation." This patent discloses an isolated peptide of up to 6 amino acids that inhibits the binding of an endothelial cell protein C receptor (EPCR) ligand to the EPCR. It also includes a molecule that comprises an amino acid sequence inhibiting this binding, attached to a heterologous moiety, along with pharmaceutical compositions and methods of treatment.

Career Highlights

Throughout his career, Joab Chapman has worked with various organizations, including Tel Hashomer Medical Research Infrastructure and Services Ltd. and Ramot University Authority for Applied Research and Industrial Development Limited. His work in these institutions has contributed to advancements in medical research and innovation.

Collaborations

Chapman has collaborated with notable individuals in his field, including Efrat Shavit-Stein. These collaborations have further enhanced his research and development efforts.

Conclusion

Joab Chapman is a distinguished inventor whose work in medical research has led to significant advancements in the identification and treatment of thrombus and inflammation. His contributions continue to impact the field positively.